BICILLIN® L-A
Effective treatment for syphilis for over 50 years 7
Based on decades of effective use, the Centers for Disease Control and Prevention (CDC) has identified penicillin G benzathine as a preferred drug for treatment of all primary, secondary, and latent syphilis, and many types of tertiary syphilis.7
BICILLIN® L-A is the only formulation of
intramuscular penicillin G benzathine that is FDA-approved for the treatment of syphilis. 10,12
Learn more about BICILLIN® L-A for treatment of syphilis.
Indicated for upper respiratory tract infections, including strep throat, and to prevent recurrence of rheumatic fever and chorea 2
BICILLIN® L-A can be used to treat infections due to penicillin-G-sensitive microorganisms susceptible to the low and very prolonged serum levels common to this dosage form. Therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. 2
BICILLIN® L-A is approved to treat the same infections in the pediatric population as in adults.2
Adjusted dosing, based on body weight, is required when treating infants and children.2
Relevant links 
Note: BICILLIN® L-A is indicated for syphilis. BICILLIN® C-R is not. 2,3 Learn about BICILLIN® C-R (penicillin G benzathine and penicillin G procaine injectable suspension).
